XFOR X4 Pharmaceuticals, Inc. - Common Stock
$4,29
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$2–$5
77% of range
Ocena Analityków
STRONG BUY
11 analysts
Cena Docelowa
$12
+170% upside
P/E (TTM)
-2.3
ROE
-83.2%
Marża Zysku Netto
-1218.5%
XFOR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$4.29
Kapitalizacja Rynkowa
$390M
P/E (TTM)
-2.3
EPS (TTM)
$-1.87
Przychody (TTM)
$6M
Stopa dywidendy
—
ROE
-83.2%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $5
XFOR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$6M
2018-12-31
→
2025-12-31
EPS
$-1.87
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-86M
2018-12-31
→
2025-12-31
Marże
-1218.5%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
XFOR
Mediana porównawcza
P/E (TTM)
-2.3
—
P/S (TTM)
60.0
289.4
P/B
2.1
2.7
Price / FCF (Cena / FCF)
-4.6
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
XFOR
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-1336.7%
—
Net Profit Margin (Marża Zysku Netto)
-1218.5%
-1021.1%
ROA
-36.2%
-57.7%
ROE
-83.2%
-69.1%
ROIC
-46.7%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
XFOR
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
10.2
8.2
Quick Ratio (Wskaźnik Szybkości)
8.4
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
XFOR
Mediana porównawcza
Revenue YoY (Przychody R/R)
150.0%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
16.7%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
XFOR
Mediana porównawcza
XFOR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
11 analityków
- Mocne kupno 5 45,5%
- Kup 5 45,5%
- Trzymaj 1 9,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
5 analityków · 2026-08-18
Mediana
$12.00
Średnia
$11.60
← Poniżej wszystkich celów
$4.29
Niski
$10.00
Wysoki
$13.00
Średni cel
$12.00
+179,7%
Średnia cel
$11.60
+170,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.77%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.13 | $-0.18 | 0.05% |
| 31 marca 2026 | $-0.16 | $-0.20 | 0.04% |
| 31 grudnia 2025 | $-0.22 | $-0.35 | 0.13% |
| 30 września 2025 | $-0.69 | $-0.93 | 0.24% |
| 30 czerwca 2025 | $-3.47 | $-4.42 | 0.95% |
| 31 marca 2025 | $0.04 | $-4.53 | 4.6% |
| 31 grudnia 2024 | $-6.00 | $-5.36 | -0.65% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | — |
| PALI | $375M | -7.8 | — | — | -25.4% | — |
| RCKT | — | — | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Cost of Revenue | $6M | $797.0K | $0 | $0 | · | · | · | · | |
| R&D Expense | $73M | $82M | $72M | $61M | $51M | $42M | $30M | $20M | |
| SG&A Expense | $44M | $62M | $36M | $27M | $25M | $21M | $18M | $9M | |
| Operating Expenses | · | $39M | $108M | $88M | $85M | $63M | $52M | $29M | |
| Operating Income | $-87M | $-36M | $-108M | $-88M | $-85M | $-60M | $-52M | $-29M | |
| Interest Expense | · | · | $6M | $4M | $4M | $3M | $2M | $720.0K | |
| Interest Income | $5M | $6M | $5M | $219.0K | $10.0K | $273.0K | $1M | $236.0K | |
| Other Non-op | $-753.0K | $332.0K | $554.0K | $-4M | $426.0K | $905.0K | $517.0K | $0 | |
| Pretax Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Income Tax | $41.0K | $310.0K | $78.0K | $28.0K | $17.0K | $148.0K | $0 | $0 | |
| Net Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| EPS (Basic) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| EPS (Diluted) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| Shares (Basic) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| Shares (Diluted) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| EBITDA | $-86M | $-36M | $-107M | $-87M | $-85M | $-60M | $-52M | $-46M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $217M | $56M | $99M | $122M | $82M | $79M | $126M | $8M | |
| Receivables | $573.0K | $1M | $0 | · | · | · | $0 | · | |
| Inventory | · | $3M | $0 | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $7M | $6M | $5M | $4M | $1M | $1M | |
| Current Assets | $262M | $112M | $122M | $129M | $88M | $83M | $129M | $9M | |
| PP&E (Net) | $182.0K | $776.0K | $745.0K | $1M | $2M | $1M | $403.0K | $241.0K | |
| PP&E (Gross) | $1M | $3M | $2M | $2M | $2M | $2M | $667.0K | $417.0K | |
| Accum. Depreciation | $1M | $2M | $2M | $1M | $724.0K | $274.0K | $264.0K | $176.0K | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $27M | $27M | $0 | |
| Intangibles | $9M | $10M | $0 | · | · | · | · | · | |
| Other Non-current Assets | $692.0K | $2M | $1M | $1M | $2M | $3M | $2M | $364.0K | |
| Total Assets | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Accounts Payable | $6M | $9M | $9M | $8M | $4M | $3M | $2M | $3M | |
| Accrued Liabilities | $19M | $23M | $13M | $12M | $8M | $8M | $6M | $3M | |
| Current Liabilities | $26M | $33M | $23M | $22M | $14M | $12M | $9M | $8M | |
| Capital Leases | $0 | $1M | $3M | $4M | $5M | $4M | $2M | · | |
| Other Non-current Liabilities | $525.0K | $831.0K | $432.0K | $173.0K | $826.0K | $462.0K | $16.0K | $205.0K | |
| Total Liabilities | $104M | $124M | $96M | $82M | $53M | $50M | $31M | $22M | |
| Long-term Debt | $75M | $75M | $55M | $32M | $32M | $32M | $20M | $10M | |
| Total Debt | · | · | $55M | $34M | $34M | · | $20M | · | |
| Common Stock | $91.0K | $6.0K | $167.0K | $122.0K | $28.0K | $16.0K | $16.0K | $0 | |
| Retained Earnings | $-595M | $-515M | $-478M | $-377M | $-283M | $-194M | $-132M | $-79M | |
| AOCI | $-109.0K | $-122.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $0 | |
| Stockholders' Equity | $186M | $22M | $51M | $74M | $64M | $73M | $129M | $-77M | |
| Liabilities + Equity | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Shares Outstanding | 90,906,920 | 5,698,231 | 167,434,595 | 121,667,250 | 28,127,657 | 16,305,731 | 16,128,862 | 351,652 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $796.0K | $419.0K | $513.0K | $499.0K | $351.0K | $103.0K | $103.0K | |
| Stock-based Comp | $4M | $8M | $9M | $5M | $6M | $5M | $2M | $759.0K | |
| Amort. of Intangibles | · | $500.0K | $0 | $0 | · | · | · | · | |
| Restructuring | $7M | $861.0K | · | · | · | · | · | $2M | |
| Other Non-cash | $-12M | $-102M | $-4M | $11M | $11M | $-2M | $3M | $-4M | |
| Operating Cash Flow | $-86M | $-131M | $-97M | $-77M | $-71M | $-59M | $-48M | $-25M | |
| CapEx | $0 | $326.0K | $60.0K | $103.0K | $615.0K | $1M | $174.0K | $0 | |
| Investing Cash Flow | $8M | $67M | $-15M | $-103.0K | $-615.0K | $-1M | $27M | $0 | |
| Net Debt Issued | $0 | $0 | $-2M | $-795.0K | $0 | $0 | $-9M | $-5M | |
| Stock Issued | $239M | $0 | $60M | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $2M | $0 | $0 | · | |
| Net Stock Activity | $239M | · | $0 | $0 | $-2M | · | · | · | |
| Financing Cash Flow | $239M | $20M | $89M | $117M | $74M | $12M | $141M | $7M | |
| Net Change in Cash | $161M | $-44M | $-23M | $40M | $2M | $-47M | $120M | $-19M | |
| Taxes Paid | $338.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-86M | $-131M | $-97M | $-77M | $-72M | $-60M | $-48M | $-41M | |
| Levered FCF | · | · | $-102M | $-81M | $-75M | $-63M | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1336.7% | -1423.6% | · | · | · | -1995.8% | · | -1311.0% | |
| Net Margin | -1218.5% | -1464.6% | · | · | · | -2071.0% | · | -1229.2% | |
| Pretax Margin | -1217.8% | -1452.5% | · | · | · | -2066.1% | · | -1229.2% | |
| EBITDA Margin | -1317.0% | -1392.5% | · | · | · | -1984.1% | · | -1306.6% | |
| ROA | -36.2% | -25.5% | -66.8% | -68.8% | -73.9% | -43.8% | -61.9% | -73.4% | |
| ROE | -83.2% | -91.6% | -170.5% | -138.1% | -133.3% | -76.5% | -50.7% | 193.4% | |
| ROIC | -46.7% | -165.7% | -101.8% | -81.4% | -86.6% | -82.4% | · | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 | 7.0 | 13.7 | 6.5 | |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 | 6.6 | 13.4 | 5.7 | |
| Debt / Equity | · | · | 1.1 | 0.5 | 0.5 | · | 0.2 | · | |
| LT Debt / Equity | · | · | 1.1 | 0.4 | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -18.6 | -21.9 | -23.4 | -22.3 | -24.1 | -44.2 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | 0.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.9 | 4.8 | · | · | · | · | · | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 150.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.7% | · | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Net Income TTM | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Market Cap | $364M | $3.76B | $4.21B | $3.62B | $1.93B | $3.15B | $5.18B | $6.09B | |
| Enterprise Value | · | · | $4.17B | $3.54B | $1.88B | · | $5.07B | · | |
| P/E | -2.1 | -3.9 | -1.5 | -19.6 | -17.2 | -62.4 | · | · | |
| P/S | 55.9 | 1447.8 | · | · | · | 1048.5 | · | · | |
| P/B | 2.0 | 170.0 | 82.5 | 48.9 | 30.0 | 43.2 | 40.1 | 281.7 | |
| P / Tangible Book | 2.3 | · | 124.9 | 63.9 | 41.1 | 68.8 | · | · | |
| P / Cash Flow | -4.2 | -28.8 | -43.7 | -47.0 | -27.3 | -53.5 | -107.7 | -148.8 | |
| P / FCF | -4.2 | -28.7 | -43.6 | -46.9 | -27.0 | -52.3 | -107.3 | -148.7 | |
| EV / EBITDA | · | · | -38.9 | -40.6 | -22.3 | · | -98.3 | · | |
| EV / FCF | · | · | -43.2 | -45.8 | -26.3 | · | -105.1 | · | |
| Earnings Yield | -46.8% | -25.4% | -67.8% | -5.1% | -5.8% | -1.6% | · | · |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $900.0K | $2M | $560.0K | $563.0K | · | $0 | $0 | $0 | · | · | · | |
| Cost of Revenue | $2M | $598.0K | $364.0K | $351.0K | $326.0K | $5M | $302.0K | $227.0K | $268.0K | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $15M | $15M | $19M | $17M | $18M | $19M | $22M | $19M | $21M | $20M | $15M | $19M | $16M | $22M | $19M | $14M | |
| SG&A Expense | $9M | $7M | $7M | $12M | $10M | $15M | $15M | $16M | $13M | $17M | $10M | $8M | $10M | $7M | $7M | $6M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | $37M | · | $27M | $26M | $29M | $26M | $20M | |
| Operating Income | $-16M | $-20M | $-24M | $-28M | $-26M | $-9M | $-36M | $-34M | $71M | $-37M | $-25M | $-27M | $-26M | $-29M | $-26M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Interest Income | $2M | $2M | $2M | $901.0K | $665.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $914.0K | $835.0K | $198.0K | $14.0K | |
| Other Non-op | $-107.0K | $14.0K | $-7.0K | $-304.0K | $-547.0K | $105.0K | $700.0K | $226.0K | $144.0K | $105.0K | $212.0K | $17.0K | $202.0K | $123.0K | $-4M | $-441.0K | |
| Pretax Income | $-16M | $-20M | $-24M | $-30M | $-26M | $316.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| Income Tax | $2.0K | $0 | $0 | $-30.0K | $37.0K | $34.0K | $258.0K | $15.0K | $18.0K | $19.0K | $33.0K | $26.0K | $15.0K | $4.0K | $14.0K | $-13.0K | |
| Net Income | $-16M | $-20M | $-24M | $-30M | $-26M | $282.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| EPS (Basic) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.93 | $-5.48 | $13.59 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| EPS (Diluted) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.91 | $-5.48 | $13.57 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| Shares (Basic) | 126,344,020 | 126,288,723 | -15,232,980 | 43,272,773 | 7,412,990 | 6,840,035 | -13,341,171 | 6,695,509 | 6,681,349 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| Shares (Diluted) | 126,344,020 | 126,288,723 | -15,262,029 | 43,272,773 | 7,412,990 | 6,869,084 | -13,353,198 | 6,695,509 | 6,693,376 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| EBITDA | $-16M | $-20M | · | $-28M | $-26M | $-9M | · | $-34M | $71M | $-37M | · | $-27M | $-26M | $-29M | · | $-20M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $195M | $217M | $217M | $70M | $39M | $40M | $56M | $97M | $147M | $60M | · | $132M | $136M | $93M | $122M | $80M | |
| Receivables | $2M | $1M | $573.0K | $891.0K | $1M | $509.0K | $1M | $0 | $0 | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $4M | $6M | $4M | $5M | $6M | · | $6M | $6M | $4M | · | $5M | |
| Current Assets | $219M | $242M | $262M | $133M | $73M | $96M | $112M | $143M | $175M | $87M | · | $148M | $148M | $98M | · | $86M | |
| PP&E (Net) | $111.0K | $146.0K | $182.0K | $218.0K | $254.0K | $487.0K | $776.0K | $820.0K | $808.0K | $742.0K | · | $772.0K | $868.0K | $986.0K | · | $1M | |
| PP&E (Gross) | $1M | $1M | $1M | · | $1M | $3M | $3M | $3M | $3M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | · | $1M | $2M | $2M | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $13M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $704.0K | $692.0K | $2M | $2M | $3M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Accounts Payable | $4M | $5M | $6M | $5M | $8M | $11M | $9M | $9M | $8M | $9M | · | $8M | $5M | $6M | · | $4M | |
| Accrued Liabilities | $14M | $17M | $19M | $17M | $13M | $13M | $23M | $19M | $20M | $13M | · | $16M | $15M | $12M | · | $9M | |
| Current Liabilities | $19M | $24M | $26M | $24M | $23M | $26M | $33M | $29M | $29M | $24M | · | $25M | $22M | $19M | · | $29M | |
| Capital Leases | · | · | $0 | $95.0K | $815.0K | $1M | $1M | $2M | $2M | $2M | · | $3M | $3M | $3M | · | $4M | |
| Other Non-current Liabilities | $523.0K | $526.0K | $525.0K | $525.0K | $535.0K | $567.0K | $831.0K | $1M | $979.0K | $1M | · | $1M | $1M | $350.0K | · | $312.0K | |
| Total Liabilities | $98M | $102M | $104M | $102M | $101M | $107M | $124M | $119M | $116M | $111M | · | $106M | $106M | $73M | · | $52M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $55M | · | $55M | $32M | $32M | · | $32M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $15M | |
| Common Stock | $96.0K | $94.0K | $91.0K | $25.0K | $8.0K | $6.0K | $6.0K | $168.0K | $168.0K | $168.0K | · | $165.0K | $164.0K | $122.0K | · | $69.0K | |
| Retained Earnings | $-631M | $-615M | $-595M | $-571M | $-541M | $-515M | $-515M | $-476M | $-439M | $-530M | · | $-459M | $-456M | $-401M | · | $-348M | |
| AOCI | $-123.0K | $-122.0K | $-109.0K | $-118.0K | $-138.0K | $-128.0K | $-122.0K | $-114.0K | $-159.0K | $-155.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | |
| Stockholders' Equity | $155M | $168M | $186M | $62M | $4M | $23M | $22M | $60M | $94M | $1M | $51M | $68M | $68M | $52M | $74M | $62M | |
| Liabilities + Equity | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Shares Outstanding | 96,114,534 | 94,319,696 | 90,906,920 | 25,146,411 | 7,959,947 | 5,788,745 | 5,698,231 | 168,511,264 | 168,196,180 | 167,937,781 | · | 164,705,712 | 164,418,011 | 122,207,488 | · | 68,734,553 |
Przepływy pieniężne 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $997.0K | $223.0K | $223.0K | $223.0K | $355.0K | $476.0K | $273.0K | $267.0K | $194.0K | $62.0K | $62.0K | $104.0K | $126.0K | $127.0K | $124.0K | $124.0K | |
| Stock-based Comp | $3M | $2M | $2M | $760.0K | $748.0K | $519.0K | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Amort. of Intangibles | · | · | · | $200.0K | · | · | · | $200.0K | $100.0K | · | · | · | · | · | · | · | |
| Restructuring | $198.0K | $37.0K | $-196.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-14M | · | · | · | $16M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-21M | $-20M | $-16M | $-28M | $-30M | $-12M | $-33M | $-34M | $-64M | $-34M | $47M | $-69M | $-48M | $-27M | $-19M | $-19M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $41.0K | $92.0K | $134.0K | $59.0K | $35.0K | $8.0K | $8.0K | $9.0K | $34.0K | $9.0K | |
| Investing Cash Flow | $-1M | $19M | $17M | $-29M | $23M | $-3M | $-9M | $-16M | $97M | $-5M | $-5M | $-5M | $-5M | $-9.0K | $-34.0K | $-9.0K | |
| Stock Issued | · | · | $146M | $87M | · | · | $0 | $-159.0K | · | · | $51M | $2.0K | · | · | · | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $443.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-443.0K | · | · | |
| Financing Cash Flow | $75.0K | $2.0K | $146M | $87M | $6M | $0 | $135.0K | $0 | $20M | $0 | $97.0K | $21M | $69M | $-2M | $61M | $52M | |
| Net Change in Cash | $-22M | $-365.0K | $147M | $30M | $-1M | $-15M | $-42M | $-50M | $87M | $-39M | $-32M | $-5M | $43M | $-29M | $42M | $32M | |
| Free Cash Flow | · | · | · | · | · | $-12M | · | · | · | $-34M | · | · | · | $-27M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-36M | · | · | · | $-28M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -683.0% | -812.2% | · | -1756.6% | -1504.1% | -1049.2% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| Net Margin | -673.2% | -809.6% | · | -1903.9% | -1476.0% | 31.3% | · | -6552.9% | 16133.8% | · | · | · | · | · | · | · | |
| Pretax Margin | -673.1% | -809.6% | · | -1905.8% | -1473.8% | 35.1% | · | -6550.2% | 16136.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -683.0% | -803.3% | · | -1756.6% | -1504.1% | -996.3% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| ROA | -9.0% | -10.1% | · | -17.4% | -16.3% | 0.23% | · | -20.9% | 62.3% | -48.9% | · | -1.3% | · | · | · | -18.5% | |
| ROE | -20.3% | -21.1% | · | -49.2% | -52.3% | 2.4% | · | -57.7% | 145.9% | -204.0% | · | -3.4% | · | · | · | -33.1% | |
| ROIC | -10.5% | -12.0% | · | -44.6% | -661.5% | -36.7% | · | -57.9% | 75.3% | -3600.7% | · | -40.7% | · | · | · | -26.3% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 10.2 | · | 5.6 | 3.2 | 3.7 | · | 4.9 | 6.1 | 3.7 | · | 5.8 | · | · | · | 3.0 | |
| Quick Ratio | 10.2 | 9.2 | · | 3.0 | 1.8 | 1.6 | · | 3.3 | 5.1 | 2.6 | · | 5.2 | · | · | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | -14.3 | 32.7 | -19.9 | · | -16.7 | -22.5 | -26.4 | · | -19.8 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 3.1 | · | 3.5 | 3.0 | 0.5 | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $7M | · | $5M | $4M | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-92M | $-76M | · | $-92M | $29M | $3M | · | $66.0K | $-19M | $-134M | · | $-104M | $-123M | $-89M | · | $-85M | |
| Market Cap | $449M | $390M | · | $86M | $15M | $41M | · | $3.38B | $2.93B | $7.00B | · | $5.39B | · | · | · | $3.53B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.25B | · | · | · | $3.46B | |
| P/E | -1.0 | -1.0 | · | -0.4 | 0.4 | 19.7 | · | 64.7 | 3.2 | -5.0 | · | -43.0 | -43.1 | -15.0 | · | -21.9 | |
| P/S | 55.0 | 58.1 | · | 18.0 | 4.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 2.3 | · | 1.4 | 3.8 | 1.8 | · | 56.7 | 31.0 | 6759.7 | · | 79.7 | · | · | · | 57.0 | |
| P / Tangible Book | 3.6 | 2.7 | · | 2.5 | · | · | · | 105.4 | 43.9 | · | · | 107.2 | · | · | · | 79.2 | |
| P / Cash Flow | · | -19.9 | · | · | · | -3.3 | · | · | -45.8 | -208.4 | · | -78.3 | · | · | · | · | |
| P / FCF | · | · | · | · | · | -3.3 | · | · | · | -208.1 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -193.1 | · | · | · | -171.7 | |
| Earnings Yield | -95.3% | -103.6% | · | -280.7% | 245.3% | 5.1% | · | 1.5% | 31.4% | -19.8% | · | -2.3% | -2.3% | -6.7% | · | -4.6% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $6M | $3M | $0 | $0 | $0 |
| Marża Operacyjna % | -1336.7% | -1423.6% | — | — | — |
| Zysk netto | $-79M | $-37M | $-101M | $-94M | $-89M |
| Rozwodniony EPS | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | 1.1 | 0.5 | 0.5 |
| Wskaźnik bieżący | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 |
| Wskaźnik Szybkości | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-86M | $-131M | $-97M | $-77M | $-72M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 92 emitenci · $429.4M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 38 (+24 vs poprzedni kw.) | 25 (+16 vs poprzedni kw.) | 19 (-2 vs poprzedni kw.) | 13 (-7 vs poprzedni kw.) | +7.8M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| MORGAN STANLEY | $44 014 736 | 9 424 997 | 10,25% | Akcje |
| FMR LLC | $38 862 138 | 8 321 657 | 9,05% | Akcje |
| Bain Capital Life Sciences Investors, LLC | $37 208 011 | 7 967 454 | 8,66% | Akcje |
| PERCEPTIVE ADVISORS LLC | $37 049 403 | 7 933 491 | 8,63% | Akcje |
| Saturn V Capital Management LP | $32 565 512 | 6 973 343 | 7,58% | Akcje |
| Empery Asset Management, LP | $32 365 860 | 6 930 591 | 7,54% | Akcje |
| Deep Track Capital, LP | $27 453 795 | 5 878 757 | 6,39% | Akcje |
| Kalehua Capital Management LLC | $17 385 663 | 3 722 840 | 4,05% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $17 353 062 | 3 715 859 | 4,04% | Akcje |
| Rosalind Advisors, Inc. | $15 012 957 | 3 214 766 | 3,50% | Akcje |
| BRAIDWELL LP | $13 649 261 | 2 922 754 | 3,18% | Akcje |
| Blackstone Inc. | $12 524 576 | 2 681 922 | 2,92% | Akcje |
| Trails Edge Capital Partners, LP | $12 008 803 | 2 571 478 | 2,80% | Akcje |
| VANGUARD GROUP INC | $11 639 808 | 2 909 952 | 2,71% | Akcje |
| Nantahala Capital Management, LLC | $11 439 016 | 2 449 468 | 2,66% | Akcje |
| BVF INC/IL | $10 431 575 | 2 233 742 | 2,43% | Akcje |
| Venrock Adviser, LLC | $9 032 962 | 1 934 253 | 2,10% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $8 383 316 | 1 794 568 | 1,95% | Akcje |
| SAMSARA BIOCAPITAL, LLC | $6 517 391 | 1 395 587 | 1,52% | Akcje |
| STATE STREET CORP | $6 052 399 | 1 296 017 | 1,41% | Akcje |
| Woodline Partners LP | $4 675 114 | 1 001 095 | 1,09% | Akcje |
| GOLDMAN SACHS GROUP INC | $4 280 223 | 916 536 | 1,00% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 671 417 | 572 038 | 0,62% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 531 738 | 542 128 | 0,59% | Akcje |
| Verdad Advisers, LP | $1 644 274 | 352 093 | 0,38% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 229 443 | 263 264 | 0,29% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 168 901 | 250 300 | 0,27% | Opcja kupna |
| Caption Management, LLC | $1 167 500 | 250 000 | 0,27% | Opcja kupna |
| Stonepine Capital Management, LLC | $1 050 699 | 224 989 | 0,24% | Akcje |
| Affinity Asset Advisors, LLC | $677 150 | 145 000 | 0,16% | Akcje |
| Nuveen, LLC | $501 507 | 107 389 | 0,12% | Akcje |
| ALPS ADVISORS INC | $447 040 | 95 726 | 0,10% | Akcje |
| RHUMBLINE ADVISERS | $444 022 | 95 081 | 0,10% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $407 607 | 87 282 | 0,09% | Akcje |
| DEUTSCHE BANK AG\ | $368 393 | 78 885 | 0,09% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $349 293 | 74 795 | 0,08% | Akcje |
| Bank of New York Mellon Corp | $327 507 | 70 130 | 0,08% | Akcje |
| WELLS FARGO & COMPANY/MN | $316 215 | 67 712 | 0,07% | Akcje |
| Palumbo Wealth Management LLC | $313 432 | 67 116 | 0,07% | Akcje |
| Squarepoint Ops LLC | $313 254 | 67 078 | 0,07% | Akcje |
| CITIGROUP INC | $305 633 | 65 446 | 0,07% | Akcje |
| MetLife Investment Management, LLC | $224 015 | 47 969 | 0,05% | Akcje |
| BANK OF AMERICA CORP /DE/ | $218 841 | 46 861 | 0,05% | Akcje |
| Point72 Asset Management, L.P. | $191 806 | 41 072 | 0,04% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $173 131 | 37 073 | 0,04% | Akcje |
| Jump Financial, LLC | $159 961 | 34 253 | 0,04% | Akcje |
| Vanguard Global Advisers, LLC | $154 003 | 32 977 | 0,04% | Akcje |
| Invesco Ltd. | $150 575 | 32 243 | 0,04% | Akcje |
| JPMORGAN CHASE & CO | $141 785 | 33 519 | 0,03% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $111 361 | 23 846 | 0,03% | Akcje |
| AXQ CAPITAL, LP | $106 850 | 22 880 | 0,02% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $103 128 | 22 083 | 0,02% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $90 719 | 19 426 | 0,02% | Akcje |
| STIFEL FINANCIAL CORP | $86 483 | 18 519 | 0,02% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $84 527 | 18 100 | 0,02% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $80 744 | 17 290 | 0,02% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $77 055 | 16 500 | 0,02% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $77 055 | 16 500 | 0,02% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $76 513 | 16 384 | 0,02% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $73 963 | 15 838 | 0,02% | Akcje |
| BARCLAYS PLC | $72 707 | 15 569 | 0,02% | Akcje |
| CAXTON CORP | $72 650 | 15 557 | 0,02% | Akcje |
| WINTON GROUP Ltd | $67 248 | 14 400 | 0,02% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65 614 | 14 050 | 0,02% | Akcje |
| Creative Planning | $64 782 | 13 872 | 0,02% | Akcje |
| BlackRock, Inc. | $64 208 | 13 749 | 0,01% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $60 215 | 14 580 | 0,01% | Akcje |
| NORTHERN TRUST CORP | $59 323 | 12 703 | 0,01% | Akcje |
| PRUDENTIAL FINANCIAL INC | $58 375 | 12 500 | 0,01% | Akcje |
| ProShare Advisors LLC | $49 445 | 10 588 | 0,01% | Akcje |
| Indivisible Partners | $46 850 | 10 000 | 0,01% | Akcje |
| Pettinga Financial Advisors LLC | $46 700 | 10 000 | 0,01% | Akcje |
| Legal & General Group Plc | $36 697 | 7 858 | 0,01% | Akcje |
| Tower Research Capital LLC (TRC) | $36 169 | 7 745 | 0,01% | Akcje |
| Ameritas Investment Partners, Inc. | $34 268 | 7 338 | 0,01% | Akcje |
| ROYAL BANK OF CANADA | $12 000 | 2 559 | 0,00% | Akcje |
| Point72 Asia (Singapore) Pte. Ltd. | $9 966 | 2 914 | 0,00% | Akcje |
| PNC Financial Services Group, Inc. | $8 215 | 1 759 | 0,00% | Akcje |
| Sterling Capital Management LLC | $7 607 | 1 629 | 0,00% | Akcje |
| CIBC Private Wealth Group LLC | $7 408 | 2 166 | 0,00% | Akcje |
| Russell Investments Group, Ltd. | $3 404 | 729 | 0,00% | Akcje |
| GROUP ONE TRADING LLC | $3 325 | 712 | 0,00% | Akcje |
| Bleichroeder LP | $2 779 | 595 | 0,00% | Akcje |
| Blue Trust, Inc. | $1 326 | 284 | 0,00% | Akcje |
| GSA CAPITAL PARTNERS LLP | $356 | 76 314 | 0,00% | Akcje |
| PRICE T ROWE ASSOCIATES INC /MD/ | $310 | 66 379 | 0,00% | Akcje |
| Rockefeller Capital Management L.P. | $154 | 33 | 0,00% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $153 | 38 | 0,00% | Akcje |
| UBS Group AG | $149 | 32 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $140 | 30 | 0,00% | Akcje |
| SBI Securities Co., Ltd. | $42 | 9 | 0,00% | Akcje |
| HighMark Wealth Management LLC | $28 | 6 | 0,00% | Akcje |
Insiderzy spółki 27 insiderów · 7 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paula Ragan | President and CEO | 17 czerwca 2019 A | 237 294 | 0 | 0 | $0 |
| Michael Gray | President, CEO and CFO | 27 listopada 2018 A | 250 000 | 0 | 0 | $0 |
| David Kirske | Chief Financial Officer | 30 czerwca 2026 S | 167 750 | 0 | 1 | $-36 393 |
| Adam S. Mostafa | CFO and Treasurer | 17 czerwca 2019 A | 10 564 | 0 | 0 | $0 |
| Lynne E Kelley | Chief Medical Officer | 24 kwietnia 2019 A | — | 0 | 0 | $0 |
| Eszter Nagy | Chief Scientific Officer | 7 marca 2018 A | — | 0 | 0 | $0 |
| David Mantus | Chief Development Officer | 7 marca 2018 A | — | 0 | 0 | $0 |
| Kelly Gold | Dyrektor | 1 lipca 2026 A | — | 0 | 0 | $0 |
| William Aliski | Dyrektor | 18 września 2019 A | — | 0 | 0 | $0 |
| Rene Russo | Dyrektor | 17 czerwca 2019 A | — | 0 | 0 | $0 |
| David W J Mcgirr | Dyrektor | 17 czerwca 2019 A | — | 0 | 0 | $0 |
| Murray Stewart | Dyrektor | 29 marca 2019 A | — | 0 | 0 | $0 |
| Gary Bridger | Dyrektor | 13 marca 2019 A | — | 0 | 0 | $0 |
| Michael S Wyzga | Dyrektor | 13 marca 2019 A | — | 0 | 0 | $0 |
| Isaac Blech | Dyrektor | 13 marca 2019 A | — | 0 | 0 | $0 |
| Tillman U. Gerngross | Dyrektor | 5 czerwca 2018 A | 392 821 | 0 | 0 | $0 |
| Claudio Nessi | Dyrektor | 5 czerwca 2018 A | 867 639 | 0 | 0 | $0 |
| Amy Schulman | Dyrektor | 5 czerwca 2018 A | — | 0 | 0 | $0 |
| William D Clark | Dyrektor | 5 czerwca 2018 A | — | 0 | 0 | $0 |
| GORDON CARL L | Dyrektor | 5 czerwca 2018 A | 1 868 966 | 0 | 0 | $0 |
| Terrance McGuire | Dyrektor | 5 czerwca 2018 A | 18 031 | 0 | 0 | $0 |
| Michael Jay Ross | Dyrektor | 15 listopada 2017 A | 1 868 961 | 0 | 0 | $0 |
| Anna-Maria & Stephen Kellen Foundation, Inc. | Posiadacz 10% | 20 listopada 2017 C | 124 381 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | Posiadacz 10% | 20 listopada 2017 C | 722 179 | 0 | 0 | $0 |
| John Volpone | — | 12 sierpnia 2026 S | 265 305 | 0 | 1 | $-109 117 |
| Adam R Craig | — | 12 sierpnia 2026 S | 328 651 | 0 | 1 | $-210 616 |
| Anthony Chris Stevens | — | 7 marca 2018 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 10 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 zgłoszenia | 29 października 2025 | 6,20% | Aneks | Inwestycja pasywna | SEC |
| Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew D. Perry | 18 sierpnia 2025 | 9,99% | Pierwotne zgłoszenie | — | SEC |
| Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP | 13 sierpnia 2025 | 9,99% | Pierwotne zgłoszenie | — | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 zgłoszenia | 17 lipca 2019 | — | Pierwotne zgłoszenie | — | SEC |
| 28 maja 2019 | — | Pierwotne zgłoszenie | — | SEC | |
| Paula Ragan, Ph.D. ×2 zgłoszenia | 26 kwietnia 2019 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×3 zgłoszenia | 19 marca 2019 | — | Pierwotne zgłoszenie | — | SEC |
| X4 Pharmaceuticals, Inc. | 6 grudnia 2018 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., SVLSF VI, LLC, SV Life Sciences Fund VI, LP., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. | 14 lutego 2018 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Joshua Makower, David M. Mott, Chetan Puttagunta, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan | 29 listopada 2017 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 13 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,53% | 25 945 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,08% | 275 116 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,02% | 750 719 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 70 293 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 1 950 293 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 464 950 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 46 744 NS | 31 maja 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 30 148 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1 031 672 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 599 387 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6 885 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,00% | 1 NS | 31 maja 2026 | N-PORT |
| ITWO · ProShares Trust | 0,00% | 1 NS | 31 maja 2026 | N-PORT |